KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $2.14.

  • Johnson & Johnson's EPS (Basic) rose 9107.14% to $2.14 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.43, marking a year-over-year increase of 7014.68%. This contributed to the annual value of $5.84 for FY2024, which is 5792.51% down from last year.
  • Latest data reveals that Johnson & Johnson reported EPS (Basic) of $2.14 as of Q3 2025, which was up 9107.14% from $2.3 recorded in Q2 2025.
  • In the past 5 years, Johnson & Johnson's EPS (Basic) ranged from a high of $10.32 in Q4 2023 and a low of -$0.19 during Q2 2023
  • Over the past 5 years, Johnson & Johnson's median EPS (Basic) value was $1.7 (recorded in 2022), while the average stood at $1.96.
  • As far as peak fluctuations go, Johnson & Johnson's EPS (Basic) tumbled by 12935.3% in 2023, and later surged by 443442.17% in 2024.
  • Over the past 5 years, Johnson & Johnson's EPS (Basic) (Quarter) stood at $1.39 in 2021, then increased by 22.3% to $1.7 in 2022, then tumbled by 101.93% to -$0.03 in 2023, then soared by 4434.42% to $1.42 in 2024, then surged by 50.7% to $2.14 in 2025.
  • Its EPS (Basic) was $2.14 in Q3 2025, compared to $2.3 in Q2 2025 and $4.57 in Q1 2025.